Prisha Palpunavam, Tan Khong Sin, Lee Chin Poo
Faculty of Information Science and Technology, Multimedia University, Jalan Ayer Keroh Lama, Bukit Beruang, Melaka 75450, Malaysia.
Faculty of Business, Multimedia University, Jalan Ayer Keroh Lama, Bukit Beruang, Melaka 75450, Malaysia.
Vaccines (Basel). 2023 Jan 7;11(1):139. doi: 10.3390/vaccines11010139.
Cervical cancer is the second most common cancer in low-income countries and the third most common cancer in Malaysia among women aged 15 to 44. This is a huge concern because of the high mortality rate compared to other countries. Cervical cancer is caused by a common sexually transmitted human papillomavirus (HPV). Of cervical cancer cases, 80% are attributed to serotypes 16 and 18; therefore, early detection of premalignant lesions and infections from these viruses is important. Diagnosis can be carried out by polymerase chain reaction (PCR)-based HPV DNA analysis and Pap smear, which act as a viable preventive strategy. (1) Background: This study determined the adoption of the human papillomavirus (HPV) vaccine and the willingness to get vaccinated in Malaysian women. (2) Methods: An online survey was conducted with women from across Malaysia to gather their views on the barriers that prevent them from accessing HPV services. Sentiment analysis was performed to detect and classify the comments into three groups (positive, neutral, and negative). (3) Results: A total of 449 opinions were received, and the findings revealed that 41.3% were not afraid to be diagnosed early, and were prepared to accept positive or negative screening results. In addition, 18.6% of those surveyed indicated that they feared a Pap smear and were very concerned that they would not get good results. Of the respondents, 36% believed in vaccination and preferred to know more about it; 43.24% claimed that their family members were very supportive towards screening and vaccination; and 21.3% felt embarrassed and were afraid to undergo the screening procedure, as they had no prior experience and were unsure of how the procedure was conducted. In addition, 40.5% indicated that they had no concerns about HPV testing and related procedures, as this information is widely available. Only a few respondents (8.1%) talked about the time constraints and busy work schedules that prevented them from going to medical appointments. The survey also revealed that women are prevented from participating in cervical cancer screening and vaccination programs due to a lack of knowledge, shyness, personal rumors, privacy issues, financial issues, a lack of access to medical services, and ignorance and beliefs about rumors spreading online. (4) Conclusion: Results indicate that awareness of HPV and related prevention measures among women is vague and that negative perceptions continue to exist. It is strongly advised to develop a well-designed and knowledge-based application on the efficacy of screening and vaccination among Malaysian women.
宫颈癌是低收入国家中第二常见的癌症,在马来西亚15至44岁的女性中则是第三常见的癌症。鉴于其死亡率相较于其他国家偏高,这是一个重大问题。宫颈癌由一种常见的性传播人类乳头瘤病毒(HPV)引发。在宫颈癌病例中,80%归因于16型和18型血清型;因此,早期检测癌前病变以及这些病毒的感染情况至关重要。诊断可通过基于聚合酶链反应(PCR)的HPV DNA分析和巴氏涂片进行,这是一种可行的预防策略。(1)背景:本研究确定了马来西亚女性对人乳头瘤病毒(HPV)疫苗的接受情况以及接种意愿。(2)方法:对来自马来西亚各地的女性进行了一项在线调查,以收集她们对阻碍其获得HPV服务的障碍的看法。进行了情感分析,以检测评论并将其分为三组(积极、中性和消极)。(3)结果:共收到449条意见,结果显示41.3%的人不害怕早期诊断,并准备接受阳性或阴性筛查结果。此外,18.6%的受访者表示她们害怕巴氏涂片检查,并且非常担心结果不理想。在受访者中,36%相信疫苗接种并希望了解更多相关信息;43.24%声称她们的家人非常支持筛查和疫苗接种;21.3%感到尴尬且害怕接受筛查程序,因为她们没有相关经验且不确定该程序如何进行。此外,40.5%表示她们对HPV检测及相关程序不担心,因为此类信息广泛可得。只有少数受访者(8.1%)谈到时间限制和繁忙的工作安排阻碍了她们去看医生。调查还显示,由于缺乏知识、害羞、个人传言、隐私问题、经济问题、无法获得医疗服务以及对网上传播的谣言的无知和信念,女性无法参与宫颈癌筛查和疫苗接种项目。(4)结论:结果表明女性对HPV及相关预防措施的认识模糊,负面看法仍然存在。强烈建议针对马来西亚女性开发一个精心设计且基于知识的关于筛查和疫苗接种效果的应用程序。